Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide and Isosorbide Dinitrate in Acute Decompensated Heart Failure
NCT02649998Withdrawn
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2017
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of furosemide and isosorbide dinitrate in heart failure (HF) (3 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Visual Analogue Scale dyspnoea score at 24 hours. Planned start Jan 2017; status: withdrawn.
02
Drugs
furosemideisosorbide dinitrate
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02649998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02649998.